tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksTop Gainers/ Losers/ Active StocksTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Top Gainers/ Losers/ Active Stocks
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

ATHA Stock Latest News

Athira Pharma to pay $4M to settle False Claims Act allegations
The FlyAthira Pharma to pay $4M to settle False Claims Act allegations
11d ago
ATHA
Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development Pipeline
PremiumCompany Announcements
Athira Pharma’s Regulatory Compliance Challenges Threaten Drug Development Pipeline
2M ago
ATHA
Athira Pharma Reports Q3 2024 Financial Results
PremiumCompany Announcements
Athira Pharma Reports Q3 2024 Financial Results
2M ago
ATHA
Athira Pharma reports Q3 EPS (75c), consensus (71c)
PremiumThe Fly
Athira Pharma reports Q3 EPS (75c), consensus (71c)
2M ago
ATHA
3 Penny Stocks to Watch Now, 11/5/24
PremiumMarket News
3 Penny Stocks to Watch Now, 11/5/24
2M ago
ATHA
TOVX
Athira Pharma to present results from Phase 2/3 LIFT-AD trial
PremiumThe FlyAthira Pharma to present results from Phase 2/3 LIFT-AD trial
3M ago
ATHA
Athira Pharma files $300M mixed securities shelf
Premium
The Fly
Athira Pharma files $300M mixed securities shelf
3M ago
ATHA
Athira Pharma downgraded to Neutral from Outperform at Mizuho
Premium
The Fly
Athira Pharma downgraded to Neutral from Outperform at Mizuho
4M ago
ATHA
Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
PremiumThe Fly
Athira Pharma to focus on ATH-1105 advancement, reduces workforce by 70%
4M ago
ATHA
Goldman Sachs moves Athira Pharma to Not Rated
PremiumThe Fly
Goldman Sachs moves Athira Pharma to Not Rated
5M ago
ATHA
Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
PremiumThe Fly
Athira Pharma downgraded to Neutral from Buy at Rodman & Renshaw
5M ago
ATHA
Athira Pharma downgraded to Market Perform from Outperform at JMP Securities
PremiumThe Fly
Athira Pharma downgraded to Market Perform from Outperform at JMP Securities
5M ago
ATHA
Athira Pharma downgraded to Neutral from Buy at BTIG
PremiumThe FlyAthira Pharma downgraded to Neutral from Buy at BTIG
5M ago
ATHA
Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings
Premium
The Fly
Closing Bell Movers: GitLab up 14%, Zscaler down 14 after earnings
5M ago
PD
ZS
Athira Pharma Discusses Clinical Trial and Financial Position
Premium
Company Announcements
Athira Pharma Discusses Clinical Trial and Financial Position
5M ago
8K
ATHA
Athira Pharma trading resumes
PremiumThe Fly
Athira Pharma trading resumes
5M ago
ATHA
Athira says clinical trial of fosgonimeton for AD primary endpoint not met
PremiumThe Fly
Athira says clinical trial of fosgonimeton for AD primary endpoint not met
5M ago
ATHA
Athira Pharma trading halted, news pending
PremiumThe Fly
Athira Pharma trading halted, news pending
5M ago
ATHA
Athira Pharma initiated with a Buy at Rodman & Renshaw
PremiumThe Fly
Athira Pharma initiated with a Buy at Rodman & Renshaw
5M ago
ATHA
ATHA Earnings this Week: How Will it Perform?
PremiumPre-EarningsATHA Earnings this Week: How Will it Perform?
5M ago
ATHA
Athira Pharma reports Q2 EPS (70c), consensus (74c)
Premium
The Fly
Athira Pharma reports Q2 EPS (70c), consensus (74c)
6M ago
ATHA
Athira Pharma presents preclinical data on fosgonimeton at AAIC
Premium
The Fly
Athira Pharma presents preclinical data on fosgonimeton at AAIC
6M ago
ATHA

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >